28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/
Related
On July 9, 2020, in an en banc opinion authored by Chief Justice Collins J. Seitz, Jr., the Delaware...
Read More >
The Occupational Safety and Health Administration (OSHA) has published a new webpage that links to r...
Read More >
On December 5, 2019, the Village of Westbury Board of Trustees adopted legislation creating the Mapl...
Read More >
The US District Court for the District of Oregon on November 2 issued a temporary restraining order ...
Read More >
Penalties and fines for non-compliance with Washington, D.C.’s law requiring D.C. employers to offe...
Read More >
In re Baker Hughes Inc. Merger Litigation, C.A. No. 2019-0638 AGB (Del. Ch. Oct. 27, 2020). This de...
Read More >